2022 ICD-10-CM Code C25.9
Malignant neoplasm of pancreas, unspecified
Valid for Submission
| ICD-10: | C25.9 |
| Short Description: | Malignant neoplasm of pancreas, unspecified |
| Long Description: | Malignant neoplasm of pancreas, unspecified |
Code Classification
C25.9 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of pancreas, unspecified. The code C25.9 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code C25.9 might also be used to specify conditions or terms like acinar cell carcinoma of pancreas, adenocarcinoma of pancreas, carcinoma of pancreas, cystadenocarcinoma of pancreas, exocrine pancreas tnm finding , exocrine pancreas tnm finding, etc.
The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: pancreas .
Unspecified diagnosis codes like C25.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C25.9 are found in the index:
- - Adenocarcinoma - See Also: Neoplasm, malignant, by site;
- - islet cell
- - with exocrine, mixed
- - unspecified site - C25.9
- - with exocrine, mixed
- - islet cell
- - Carcinoma (malignant) - See Also: Neoplasm, by site, malignant;
- - islet cell
- - with exocrine, mixed
- - unspecified site - C25.9
- - with exocrine, mixed
- - islet cell
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Acinar cell carcinoma of pancreas
- Adenocarcinoma of pancreas
- Carcinoma of pancreas
- Cystadenocarcinoma of pancreas
- Exocrine pancreas TNM finding
- Exocrine pancreas TNM finding
- Exocrine pancreas TNM finding
- Exocrine pancreas TNM finding
- Exocrine pancreas TNM finding
- Exocrine pancreas TNM finding
- Familial malignant neoplasm of pancreas
- Intraductal papillary mucinous neoplasm of pancreas
- Invasive intraductal papillary-mucinous carcinoma of pancreas
- Local recurrence of malignant tumor of pancreas
- Malignant tumor of pancreas
- Metastasis from malignant tumor of pancreas
- Mucinous cystadenocarcinoma of pancreas
- Mucinous cystic neoplasm with invasive carcinoma of pancreas
- pN1a category
- pN1a: Metastasis in single regional lymph node
- pN1b category
- pN1b: Metastasis in multiple regional lymph node
- Primary adenocarcinoma of pancreas
- Primary malignant neoplasm of pancreas
- pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension
- pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension
- pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery
- pT4: Tumor involves the celiac axis or the superior mesenteric artery
- Serous cystadenocarcinoma of pancreas
- Solid pseudopapillary carcinoma of pancreas
- Squamous cell carcinoma of exocrine pancreas
- T1: Tumor limited to pancreas and < 2 cm in greatest dimension
- T2: Tumor limited to pancreas and > 2 cm in greatest dimension
- T3: Pancreatic tumor extends directly to any of the following: duodenum; bile duct; peripancreatic tissues
- T4: Pancreas tumor extends directly to any of the following: stomach; spleen; colon; adjacent large vessels
- Tumor invades beyond pancreatic capsule to adjacent large vessels
- Tumor invades beyond pancreatic capsule to adjacent structures AND/OR organs
- Tumor invades beyond pancreatic capsule to bile duct
- Tumor invades beyond pancreatic capsule to colon
- Tumor invades beyond pancreatic capsule to duodenum
- Tumor invades beyond pancreatic capsule to spleen
- Tumor invades beyond pancreatic capsule to stomach
- Tumor invades beyond pancreatic capsule, but does not invade adjacent structures AND/OR organs
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code C25.9 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
| MS-DRG | MS-DRG Title | MCD | Relative Weight |
|---|---|---|---|
| 435 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC | 07 | 1.7528 |
| 436 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC | 07 | 1.1202 |
| 437 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC | 07 | 0.8945 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert C25.9 to ICD-9 Code
- 157.9 - Malig neo pancreas NOS
Table of Neoplasms
The code C25.9 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
| Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
|---|---|---|---|---|---|---|
| »pancreas | C25.9 | C78.89 | D01.7 | D13.6 | D37.8 | D49.0 |
Information for Patients
Pancreatic Cancer
The pancreas is a gland behind your stomach and in front of your spine. It produces the juices that help break down food and the hormones that help control blood sugar levels. Pancreatic cancer usually begins in the cells that produce the juices. Some risk factors for developing pancreatic cancer include
- Smoking
- Long-term diabetes
- Chronic pancreatitis
- Certain hereditary disorders
Pancreatic cancer is hard to catch early. It doesn't cause symptoms right away. When you do get symptoms, they are often vague or you may not notice them. They include yellowing of the skin and eyes, pain in the abdomen and back, weight loss and fatigue. Also, because the pancreas is hidden behind other organs, health care providers cannot see or feel the tumors during routine exams. Doctors use a physical exam, blood tests, imaging tests, and a biopsy to diagnose it.
Because it is often found late and it spreads quickly, pancreatic cancer can be hard to treat. Possible treatments include surgery, radiation, chemotherapy, and targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Pancreatic Cancer Summary Learn about pancreatic cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)